Manufacturer record
Systole Remedies Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Systole Remedies Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between April 2023 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
11 records linked to Systole Remedies Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cloxase-SP | TG25115EMfg 2025-07 · Exp 2027-06 | The sample does not confirm to IP2022 requirement withespect to,"UNIFOR+Q130:Q131MITY OF WEIGHTS"Weight | DTL,Dalgate Srinagar Kashmir, J&KState lab | Mar 2026 |
| (Telmisartan & Amlodipine Tablets) | TG24K067AMfg 2024-11 · Exp 2026-10 | Assay of Amlodipine and test for Dissolution of Amlodipine & Telmisartan onlyAssay | RDTL, Hubli, KarnatakaState lab | Mar 2026 |
| Telmisartan Tablets IP | TG25C049AMfg 2025-03 · Exp 2027-02 | Sample fails the test Dissolution as per IP.Dissolution | DTL ThrissurState lab | Feb 2026 |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | SRLF250099Mfg 2025-06 · Exp 2027-05 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Tablets of Supator-20 (AtorvastatinTablets IP 20mg) | SRTB240152Mfg 2024-02 · Exp 2026-01 | Content of AtorvastatinOther | SDT&RL, BhubaneswarState lab | Nov 2025 |
| Trypsin, Bromelain, Rutoside, Trihydrate & Diclofenac Tablets (RUMIHEAL-D) | SRTF240703BMfg 2024-06 · Exp ? | Test for DisintegrationDisintegration | DTL Baddi Distt Solan HPState lab | May 2025 |
| Ceftriaxone Injection IP (Cefiglad-1 Injection) | SRIJ240041Mfg 2024-10 · Exp 2026-09 | Particulate matterParticulate matter | RDTL ChandigarhCDSCO lab | Jan 2025 |
| Acyclovir Dispersible Tablets IP (Zovibact 800 mg) | SRTH230874 BMfg 2023-08 · Exp 2025-07 | Uniformity of dispersion & DisintegrationDisintegration | RDTL GuwahatiCDSCO lab | Dec 2024 |
| Methylcobalami n Injection 2500 mcg (NUROFENS- 2500 Injection) | SRID24010 1Mfg 2024-04 · Exp 2025-09 | Particulate matter and Assay of Methylcobalami nAssay | RDTL ChandigarhCDSCO lab | Sep 2024 |
| Ambroxol, Terbutaline Sulphate, Guaiphenesin and Menthol Syrup (Tricodex A Syrup) | SRLK230054Mfg 2023-11 · Exp 2025-10 | Assay of Terbutaline SulphateAssay | RDTL ChandigarhCDSCO lab | Feb 2024 |
| Pantoprazole (EC) & Domperidone (SR) Capsules I.P. GFree� - D | CF0552Mfg 2022-06 · Exp 2024-05 | Assay of PantoprazoleAssay | RDTL GuwahatiState lab | Apr 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.